BackContineum Therapeutics Overview

Contineum Therapeutics Operating Income

Operating Income for CTNM.

Quarterly Operating Income

$-16904000.00
↓ 6.66% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-66853000.00
↑ 13.17% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin